One major mechanism is that adiponectin can decrease blood insulin levels [5,33–35], and therefore can inhibit cancer development, as the insulin-upregulated estrogen is one of the predominant risk factor for endometrial cancer [13,20,32,36,37]. This evidence concerns the gene ADIPOQ and cancer.